HCA Healthcare, Inc. (HCA)

HCA Healthcare executives recently executed significant divestments, totaling over $16 million in net value during the past quarter. These transactions occurred following a positive earnings report where the firm beat expectations. Despite a 19.8% stock price increase over ninety days, leadership activity remains exclusively focused on selling shares rather than acquiring new equity positions.
Ticker: HCA Exchange: NYS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for HCA Healthcare, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
61.27
Quantity 86,544 +14.4%
Value US$2,567,914
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
249.44
Quantity 59,400 +45.7%
Value US$3,979,784
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
77.09
Quantity 38,667 -35.6%
Value US$396,925
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
495.85
Quantity 1,000 -9.6%
Value US$100,000
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
496.92
Quantity 1,000 -3.7%
Value US$100,000
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
498.00
Quantity 1,000 -5.5%
Value US$100,000
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
498.97
Quantity 1,000 -2.8%
Value US$100,000
Schlosser Michael J EVP and Chief Clinical Officer Officer
Transaction date
Sale
Price
494.65
Quantity 1,000 -45.4%
Value US$100,000
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
514.07
Quantity 1,000 -100.0%
Value US$100,000
2.5
Jon M Foster OFFICER Officer
Transaction date
Proposed sale
Price
514.07
Quantity 1,000
Value US$100,000
Michael J Schlosser Officer Officer
Transaction date
Proposed sale
Price
494.65
Quantity 1,000
Value US$100,000
2.8
Michael S Cuffe Officer Officer
Transaction date
Proposed sale
Price
477.00
Quantity 1,000
Value US$100,000
2.7
McAlevey Michael R EVP & Chief Legal & Admin Off. Officer
Transaction date
Sale
Price
533.37
Quantity 1,694 -16.1%
Value US$903,537
2.7
Michael R McAlevey OFFICER Officer
Transaction date
Proposed sale
Price
533.34
Quantity 1,694
Value US$903,486
2.9
Wyatt Christopher F. SVP & Controller Officer
Transaction date
Sale
Price
505.00
Quantity 4,000 -8.3%
Value US$2,020,000
2.7
Berres Jennifer SVP & Chief Human Res. Officer Officer
Transaction date
Sale
Price
526.16
Quantity 4,010 -25.1%
Value US$2,109,920
2.7
Berres Jennifer SVP & Chief Human Res. Officer Officer
Transaction date
Sale
Price
503.00
Quantity 4,010 -20.0%
Value US$2,017,030
2.7
Jennifer L. Berres OFFICER Officer
Transaction date
Proposed sale
Price
514.58
Quantity 8,020
Value US$4,126,950
2.4
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
497.18
Quantity 120 -0.4%
Value US$59,661
2.4
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
498.12
Quantity 4,293 -11.7%
Value US$2,138,442
2.4
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
498.80
Quantity 5,162 -12.3%
Value US$2,574,794
2.4
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
500.02
Quantity 6,189 -12.9%
Value US$3,094,609
2.4
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
500.69
Quantity 7,395 -13.3%
Value US$3,702,626
2.4
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
502.15
Quantity 5,002 -8.3%
Value US$2,511,757
2.4
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
502.95
Quantity 14,716 -19.6%
Value US$7,401,386
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Sale
Price
498.09
Quantity 1,500 -4.8%
Value US$747,135
2.8
MICHAEL S CUFFE OFFICER Officer
Transaction date
Proposed sale
Price
498.09
Quantity 1,500
Value US$747,135
2.4
Samuel N. Hazen President, Chief Executive Officer & Director Executive Director
Transaction date
Proposed sale
Price
501.04
Quantity 42,877
Value US$21,483,274
2.7
Michael R McAlevey OFFICER Officer
Transaction date
Proposed sale
Price
473.79
Quantity 3,892
Value US$1,843,991
2.7
McAlevey Michael R EVP & Chief Legal & Admin Off. Officer
Transaction date
Sale
Price
473.79
Quantity 3,892 -52.7%
Value US$1,843,991
2.8
Cuffe Michael S. Officer Officer
Transaction date
Proposed sale
Price
418.84
Quantity 3,836
Value US$1,606,670
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Planned sale
Price
418.84
Quantity 3,836 -10.9%
Value US$1,606,670
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
369.32
Quantity 15,698 -55.4%
Value US$5,797,661
2.5
Foster Jon M Officer Officer
Transaction date
Proposed sale
Price
369.32
Quantity 15,698
Value US$5,797,660
2.7
Berres Jennifer SVP & Chief Human Res. Officer Officer
Transaction date
Sale
Price
322.31
Quantity 5,378 -25.9%
Value US$1,733,362
2.7
Berres Jennifer SVP & Chief Human Res. Officer Officer
Transaction date
Sale
Price
322.96
Quantity 4,155 -16.7%
Value US$1,341,878
2.7
Berres Jennifer Officer Officer
Transaction date
Proposed sale
Price
322.59
Quantity 9,533
Value US$3,075,238
2.5
Reiner Deborah M Former Officer Officer
Transaction date
Proposed sale
Price
322.39
Quantity 3,510
Value US$1,131,589
3.0
Whalen Kathleen M Former Officer Officer
Transaction date
Proposed sale
Price
335.26
Quantity 3,228
Value US$1,082,203
3.0
Whalen Kathleen M SVP & Chief Ethics Officer Officer
Transaction date
Sale
Price
357.99
Quantity 1,474 -13.5%
Value US$527,677
3.0
Whalen Kathleen M Officer Officer
Transaction date
Proposed sale
Price
357.99
Quantity 1,474
Value US$527,677
3.2
Akdamar Erol R Officer Officer
Transaction date
Proposed sale
Price
357.86
Quantity 4,872
Value US$1,743,480
Billington Phillip G Officer Officer
Transaction date
Proposed sale
Price
350.00
Quantity 3,897
Value US$1,363,950
3.2
Akdamar Erol R Group President Officer
Transaction date
Sale
Price
353.00
Quantity 2,900 -29.8%
Value US$1,023,700
Billington Phillip G SVP-Internal Audit Services Officer
Transaction date
Planned sale
Price
350.00
Quantity 3,897 -6.9%
Value US$1,363,950
2.8
Cuffe Michael S. Officer Officer
Transaction date
Proposed sale
Price
385.42
Quantity 8,358
Value US$3,221,340
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Planned sale
Price
385.42
Quantity 8,358 -22.0%
Value US$3,221,340
3.0
Whalen Kathleen M Officer Officer
Transaction date
Proposed sale
Price
363.51
Quantity 2,987
Value US$1,085,804
3.0
Whalen Kathleen M SVP & Chief Ethics Officer Officer
Transaction date
Sale
Price
363.51
Quantity 2,987 -24.0%
Value US$1,085,804
3.0
Whalen Kathleen M SVP & Chief Ethics Officer Officer
Transaction date
Sale
Price
359.92
Quantity 1,864 -13.0%
Value US$670,891
2.5
Reiner Deborah M SVP - Mktg. & Communications Officer
Transaction date
Sale
Price
359.96
Quantity 3,314 -48.6%
Value US$1,192,914
2.9
Wyatt Christopher F. Officer Officer
Transaction date
Proposed sale
Price
360.20
Quantity 4,000
Value US$1,440,783
2.5
Reiner Deborah M Officer Officer
Transaction date
Proposed sale
Price
359.96
Quantity 3,314
Value US$1,192,914
3.0
Whalen Kathleen M Officer Officer
Transaction date
Proposed sale
Price
359.92
Quantity 1,864
Value US$670,891
2.9
Wyatt Christopher F. SVP & Controller Officer
Transaction date
Sale
Price
360.20
Quantity 4,000 -9.0%
Value US$1,440,782
3.0
Torres Kathryn A. SVP-Payer Contracting & Align. Officer
Transaction date
Sale
Price
355.05
Quantity 1,857 -9.5%
Value US$659,328
3.0
Torres Kathryn A. Officer Officer
Transaction date
Proposed sale
Price
355.05
Quantity 1,857
Value US$659,328
3.0
Whalen Kathleen M SVP & Chief Ethics Officer Officer
Transaction date
Sale
Price
326.30
Quantity 3,204 -25.3%
Value US$1,045,465
3.0
Whalen Kathleen M Officer Officer
Transaction date
Proposed sale
Price
326.30
Quantity 3,204
Value US$1,045,465
3.0
Torres Kathryn A. SVP-Payer Contracting & Align. Officer
Transaction date
Sale
Price
326.18
Quantity 1,863 -8.7%
Value US$607,673
3.0
Torres Kathryn A. Officer Officer
Transaction date
Proposed sale
Price
326.18
Quantity 1,863
Value US$607,673
1.8
Cohen Jeffrey E. SVP-Government Relations Officer
Transaction date
Sale
Price
313.00
Quantity 1,650 -24.1%
Value US$516,450
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Sale
Price
316.88
Quantity 6,311 -17.6%
Value US$1,999,825
1.8
Cohen Jeffrey E. Officer Officer
Transaction date
Proposed sale
Price
313.00
Quantity 1,650
Value US$516,450
2.8
Cuffe Michael S. Officer Officer
Transaction date
Proposed sale
Price
316.88
Quantity 6,311
Value US$1,999,824
2.8
RUTHERFORD BILL B Former Officer Officer
Transaction date
Proposed sale
Price
311.36
Quantity 15,000
Value US$4,670,373
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Planned sale
Price
309.00
Quantity 1,600 -4.5%
Value US$494,400
2.8
Cuffe Michael S. Officer Officer
Transaction date
Proposed sale
Price
309.00
Quantity 1,600
Value US$494,400
3.0
Torres Kathryn A. SVP-Payer Contracting & Align. Officer
Transaction date
Sale
Price
312.00
Quantity 890 -4.0%
Value US$277,680
3.0
Torres Kathryn A. SVP-Payer Contracting & Align. Officer
Transaction date
Sale
Price
312.00
Quantity 973 -4.2%
Value US$303,576
3.0
Torres Kathryn A. Officer Officer
Transaction date
Proposed sale
Price
312.00
Quantity 1,863
Value US$581,256
Wasserman Chad J Officer Officer
Transaction date
Proposed sale
Price
330.25
Quantity 876
Value US$289,299
Wasserman Chad J SVP and CIO Officer
Transaction date
Planned sale
Price
330.25
Quantity 876 -35.7%
Value US$289,299
Wasserman Chad J SVP and CIO Officer
Transaction date
Planned sale
Price
321.97
Quantity 344 -12.3%
Value US$110,758
Wasserman Chad J Officer Officer
Transaction date
Proposed sale
Price
321.97
Quantity 344
Value US$110,758
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-06 2026-11-06 S Sale

EVP and COO

Officer
86,544 +14.4%
61.27
US$2,567,914
86,544 +14.4% 61.27 US$2,567,914
2026-11-06 2026-11-06 S Sale

EVP and COO

Officer
59,400 +45.7%
249.44
US$3,979,784
59,400 +45.7% 249.44 US$3,979,784
2026-11-06 2026-11-06 S Sale

EVP and COO

Officer
38,667 -35.6%
77.09
US$396,925
38,667 -35.6% 77.09 US$396,925
2026-11-06 2026-11-06 S Sale

EVP and COO

Officer
1,000 -9.6%
495.85
US$100,000
1,000 -9.6% 495.85 US$100,000
2026-11-06 2026-11-06 S Sale

EVP and COO

Officer
1,000 -3.7%
496.92
US$100,000
1,000 -3.7% 496.92 US$100,000
2026-11-06 2026-11-06 S Sale

EVP and COO

Officer
1,000 -5.5%
498.00
US$100,000
1,000 -5.5% 498.00 US$100,000
2026-11-06 2026-11-06 S Sale

EVP and COO

Officer
1,000 -2.8%
498.97
US$100,000
1,000 -2.8% 498.97 US$100,000
2026-11-06 2026-11-04 S Sale

EVP and Chief Clinical Officer

Officer
1,000 -45.4%
494.65
US$100,000
1,000 -45.4% 494.65 US$100,000
2026-11-06 2026-11-04 S Sale

EVP and COO

Officer
1,000 -100.0%
514.07
US$100,000
1,000 -100.0% 514.07 US$100,000
2026-11-04 2026-11-04 PrS Proposed sale

OFFICER

Officer
1,000
514.07
US$100,000
1,000 514.07 US$100,000
2026-11-04 2026-11-04 PrS Proposed sale

Officer

Officer
1,000
494.65
US$100,000
1,000 494.65 US$100,000
2026-10-29 2026-10-29 PrS Proposed sale

Officer

Officer
1,000
477.00
US$100,000
1,000 477.00 US$100,000
2026-02-18 2026-02-18 S Sale

EVP & Chief Legal & Admin Off.

Officer
1,694 -16.1%
533.37
US$903,537
1,694 -16.1% 533.37 US$903,537
2026-02-18 2026-02-18 PrS Proposed sale

OFFICER

Officer
1,694
533.34
US$903,486
1,694 533.34 US$903,486
2026-02-12 2026-02-11 S Sale

SVP & Controller

Officer
4,000 -8.3%
505.00
US$2,020,000
4,000 -8.3% 505.00 US$2,020,000
2026-02-12 2026-02-11 S Sale

SVP & Chief Human Res. Officer

Officer
4,010 -25.1%
526.16
US$2,109,920
4,010 -25.1% 526.16 US$2,109,920
2026-02-12 2026-02-11 S Sale

SVP & Chief Human Res. Officer

Officer
4,010 -20.0%
503.00
US$2,017,030
4,010 -20.0% 503.00 US$2,017,030
2026-02-11 2026-02-11 PrS Proposed sale

OFFICER

Officer
8,020
514.58
US$4,126,950
8,020 514.58 US$4,126,950
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
120 -0.4%
497.18
US$59,661
120 -0.4% 497.18 US$59,661
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
4,293 -11.7%
498.12
US$2,138,442
4,293 -11.7% 498.12 US$2,138,442
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
5,162 -12.3%
498.80
US$2,574,794
5,162 -12.3% 498.80 US$2,574,794
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
6,189 -12.9%
500.02
US$3,094,609
6,189 -12.9% 500.02 US$3,094,609
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
7,395 -13.3%
500.69
US$3,702,626
7,395 -13.3% 500.69 US$3,702,626
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
5,002 -8.3%
502.15
US$2,511,757
5,002 -8.3% 502.15 US$2,511,757
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
14,716 -19.6%
502.95
US$7,401,386
14,716 -19.6% 502.95 US$7,401,386
2026-02-05 2026-02-03 S Sale

EVP and Chief Clinical Officer

Officer
1,500 -4.8%
498.09
US$747,135
1,500 -4.8% 498.09 US$747,135
2026-02-03 2026-02-03 PrS Proposed sale

OFFICER

Officer
1,500
498.09
US$747,135
1,500 498.09 US$747,135
2026-02-03 2026-02-03 PrS Proposed sale

President, Chief Executive Officer & Director

Executive Director
42,877
501.04
US$21,483,274
42,877 501.04 US$21,483,274
2025-11-05 2025-11-05 PrS Proposed sale

OFFICER

Officer
3,892
473.79
US$1,843,991
3,892 473.79 US$1,843,991
2025-11-05 2025-11-05 S Sale

EVP & Chief Legal & Admin Off.

Officer
3,892 -52.7%
473.79
US$1,843,991
3,892 -52.7% 473.79 US$1,843,991
2025-09-08 2025-09-08 PrS Proposed sale

Officer

Officer
3,836
418.84
US$1,606,670
3,836 418.84 US$1,606,670
2025-09-08 2025-09-08 PlS Planned sale

EVP and Chief Clinical Officer

Officer
3,836 -10.9%
418.84
US$1,606,670
3,836 -10.9% 418.84 US$1,606,670
2025-05-15 2025-05-13 S Sale

EVP and COO

Officer
15,698 -55.4%
369.32
US$5,797,661
15,698 -55.4% 369.32 US$5,797,661
2025-05-13 2025-05-13 PrS Proposed sale

Officer

Officer
15,698
369.32
US$5,797,660
15,698 369.32 US$5,797,660
2025-02-18 2025-02-14 S Sale

SVP & Chief Human Res. Officer

Officer
5,378 -25.9%
322.31
US$1,733,362
5,378 -25.9% 322.31 US$1,733,362
2025-02-18 2025-02-14 S Sale

SVP & Chief Human Res. Officer

Officer
4,155 -16.7%
322.96
US$1,341,878
4,155 -16.7% 322.96 US$1,341,878
2025-02-14 2025-02-14 PrS Proposed sale

Officer

Officer
9,533
322.59
US$3,075,238
9,533 322.59 US$3,075,238
2025-02-11 2025-02-11 PrS Proposed sale

Former Officer

Officer
3,510
322.39
US$1,131,589
3,510 322.39 US$1,131,589
2025-01-31 2025-01-31 PrS Proposed sale

Former Officer

Officer
3,228
335.26
US$1,082,203
3,228 335.26 US$1,082,203
2024-11-18 2024-11-14 S Sale

SVP & Chief Ethics Officer

Officer
1,474 -13.5%
357.99
US$527,677
1,474 -13.5% 357.99 US$527,677
2024-11-14 2024-11-14 PrS Proposed sale

Officer

Officer
1,474
357.99
US$527,677
1,474 357.99 US$527,677
2024-11-14 2024-11-14 PrS Proposed sale

Officer

Officer
4,872
357.86
US$1,743,480
4,872 357.86 US$1,743,480
2024-11-14 2024-11-14 PrS Proposed sale

Officer

Officer
3,897
350.00
US$1,363,950
3,897 350.00 US$1,363,950
2024-11-14 2024-11-14 S Sale

Group President

Officer
2,900 -29.8%
353.00
US$1,023,700
2,900 -29.8% 353.00 US$1,023,700
2024-11-14 2024-11-14 PlS Planned sale

SVP-Internal Audit Services

Officer
3,897 -6.9%
350.00
US$1,363,950
3,897 -6.9% 350.00 US$1,363,950
2024-09-12 2024-09-12 PrS Proposed sale

Officer

Officer
8,358
385.42
US$3,221,340
8,358 385.42 US$3,221,340
2024-09-12 2024-09-12 PlS Planned sale

EVP and Chief Clinical Officer

Officer
8,358 -22.0%
385.42
US$3,221,340
8,358 -22.0% 385.42 US$3,221,340
2024-07-31 2024-07-31 PrS Proposed sale

Officer

Officer
2,987
363.51
US$1,085,804
2,987 363.51 US$1,085,804
2024-07-31 2024-07-31 S Sale

SVP & Chief Ethics Officer

Officer
2,987 -24.0%
363.51
US$1,085,804
2,987 -24.0% 363.51 US$1,085,804
2024-07-31 2024-07-29 S Sale

SVP & Chief Ethics Officer

Officer
1,864 -13.0%
359.92
US$670,891
1,864 -13.0% 359.92 US$670,891
2024-07-31 2024-07-29 S Sale

SVP - Mktg. & Communications

Officer
3,314 -48.6%
359.96
US$1,192,914
3,314 -48.6% 359.96 US$1,192,914
2024-07-29 2024-07-29 PrS Proposed sale

Officer

Officer
4,000
360.20
US$1,440,783
4,000 360.20 US$1,440,783
2024-07-29 2024-07-29 PrS Proposed sale

Officer

Officer
3,314
359.96
US$1,192,914
3,314 359.96 US$1,192,914
2024-07-29 2024-07-29 PrS Proposed sale

Officer

Officer
1,864
359.92
US$670,891
1,864 359.92 US$670,891
2024-07-29 2024-07-29 S Sale

SVP & Controller

Officer
4,000 -9.0%
360.20
US$1,440,782
4,000 -9.0% 360.20 US$1,440,782
2024-07-29 2024-07-25 S Sale

SVP-Payer Contracting & Align.

Officer
1,857 -9.5%
355.05
US$659,328
1,857 -9.5% 355.05 US$659,328
2024-07-25 2024-07-25 PrS Proposed sale

Officer

Officer
1,857
355.05
US$659,328
1,857 355.05 US$659,328
2024-05-20 2024-05-16 S Sale

SVP & Chief Ethics Officer

Officer
3,204 -25.3%
326.30
US$1,045,465
3,204 -25.3% 326.30 US$1,045,465
2024-05-16 2024-05-16 PrS Proposed sale

Officer

Officer
3,204
326.30
US$1,045,465
3,204 326.30 US$1,045,465
2024-05-17 2024-05-15 S Sale

SVP-Payer Contracting & Align.

Officer
1,863 -8.7%
326.18
US$607,673
1,863 -8.7% 326.18 US$607,673
2024-05-15 2024-05-15 PrS Proposed sale

Officer

Officer
1,863
326.18
US$607,673
1,863 326.18 US$607,673
2024-05-13 2024-05-09 S Sale

SVP-Government Relations

Officer
1,650 -24.1%
313.00
US$516,450
1,650 -24.1% 313.00 US$516,450
2024-05-13 2024-05-09 S Sale

EVP and Chief Clinical Officer

Officer
6,311 -17.6%
316.88
US$1,999,825
6,311 -17.6% 316.88 US$1,999,825
2024-05-09 2024-05-09 PrS Proposed sale

Officer

Officer
1,650
313.00
US$516,450
1,650 313.00 US$516,450
2024-05-09 2024-05-09 PrS Proposed sale

Officer

Officer
6,311
316.88
US$1,999,824
6,311 316.88 US$1,999,824
2024-05-07 2024-05-07 PrS Proposed sale

Former Officer

Officer
15,000
311.36
US$4,670,373
15,000 311.36 US$4,670,373
2024-05-08 2024-05-06 PlS Planned sale

EVP and Chief Clinical Officer

Officer
1,600 -4.5%
309.00
US$494,400
1,600 -4.5% 309.00 US$494,400
2024-05-06 2024-05-06 PrS Proposed sale

Officer

Officer
1,600
309.00
US$494,400
1,600 309.00 US$494,400
2024-05-06 2024-05-03 S Sale

SVP-Payer Contracting & Align.

Officer
890 -4.0%
312.00
US$277,680
890 -4.0% 312.00 US$277,680
2024-05-06 2024-05-02 S Sale

SVP-Payer Contracting & Align.

Officer
973 -4.2%
312.00
US$303,576
973 -4.2% 312.00 US$303,576
2024-05-02 2024-05-02 PrS Proposed sale

Officer

Officer
1,863
312.00
US$581,256
1,863 312.00 US$581,256
2024-03-20 2024-03-20 PrS Proposed sale

Officer

Officer
876
330.25
US$289,299
876 330.25 US$289,299
2024-03-20 2024-03-20 PlS Planned sale

SVP and CIO

Officer
876 -35.7%
330.25
US$289,299
876 -35.7% 330.25 US$289,299
2024-03-20 2024-03-18 PlS Planned sale

SVP and CIO

Officer
344 -12.3%
321.97
US$110,758
344 -12.3% 321.97 US$110,758
2024-03-18 2024-03-18 PrS Proposed sale

Officer

Officer
344
321.97
US$110,758
344 321.97 US$110,758

See older HCA Healthcare, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock HCA Healthcare, Inc. history with Plus

Billed monthly · Cancel anytime